BAP Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Credicorp Ltd (BAP) is not a strong buy right now for a beginner long-term investor, even with $50,000-$100,000 available. The business fundamentals are solid and the latest quarter showed strong earnings growth, but the current technical setup is neutral to slightly weak, there is no supportive Intellectia buy signal today, and the near-term price trend points lower. My clear view: hold and wait for a better entry rather than buying immediately.
BAP is trading at 321.77, just below the pivot at 322.507, with resistance at 328.428 and support at 316.586. RSI_6 at 45.27 is neutral, showing neither oversold nor overbought conditions. MACD histogram is -0.518 and still below zero, which signals bearish momentum, although the negative momentum is contracting. Moving averages are converging, suggesting the stock is not in a strong trend and may be setting up for a move, but not yet confirmed upward. The provided trend model also suggests weakness over the next week and month, which supports a cautious stance.
["Q4 2025 revenue rose 7.67% YoY to 5.95B", "Q4 2025 net income grew 40.85% YoY to 1.59B", "Q4 2025 EPS grew 41.23% YoY to 19.97", "UBS raised its price target to $408 from $318 and kept a Buy rating", "Upcoming Q1 2026 earnings report on May 14, 2026 could act as a catalyst"]
["MACD is still negative, showing weak momentum", "RSI is neutral, not a strong entry signal", "Near-term trend model points to potential downside over the next week and month", "No AI Stock Picker signal today", "No SwingMax signal recently", "Hedge funds and insiders are neutral, with no notable recent buying support", "No recent congress trading data available"]
In Q4 2025, Credicorp delivered strong growth: revenue increased 7.67% YoY, net income increased 40.85% YoY, and EPS increased 41.23% YoY. This is a very healthy latest-quarter performance and shows improving profitability. For a long-term investor, that is a positive fundamental base, and the upcoming Q1 2026 results on May 14, 2026 are an important next check on whether this growth is continuing.
The analyst trend is positive: UBS on 2026-04-21 raised the price target to $408 from $318 and maintained a Buy rating. That is a meaningful upward revision and indicates Wall Street sees upside. Still, the broader pros-and-cons view is mixed: the upside case is supported by earnings growth and a higher target, while the downside case is that current momentum is weak, technicals are not confirming a breakout, and there is no supportive proprietary trading signal today.
